The startup aims to develop a more affordable at-home alternative to IVF.
A startup that has created an at-home fertility treatment device for consumers has just secured $3.2 million from Octopus Ventures.
"A lot of options are out of alignment — so we've opened the fertility pathway and created a treatment that's more affordable."
The startup is offering a medical device and treatment kit that delivers ICI.
The startup is gearing up to launch a pilot program with the UK's National Health Service and enroll its users in a fertility treatment study.
Persons:
Tess Cosad, we've, It's
Organizations:
Octopus Ventures, ICI, UK's National Institute of Health, National Health Service, UK, Vira Health, Forward Partners, Q Ventures, NHS
Locations:
COVID, Vira, JamJar